Table. Patient, Tumor, and Treatment Characteristics.
| Characteristic | No. (%) |
|---|---|
| Total, No. | 109 |
| Sex | |
| Male | 81 (74.3) |
| Female | 28 (25.7) |
| Race/ethnicity | |
| Asian | 1 (0.9) |
| Hispanic | 5 (4.6) |
| White | 103 (94.5) |
| Age, median (range), y | 66 (40-91) |
| Smoking history | |
| Yes | 51 (46.8) |
| No | 58 (53.2) |
| Sign of ocular area on presentation | |
| Primary | 66 (60.6) |
| Recurrent | 43 (39.4) |
| Nonmelanoma skin cancer elsewhere | |
| Yes | 48 (44.0) |
| No | 61 (56.0) |
| Immunosuppression | |
| Yes | 8 (7.3) |
| No | 101 (92.7) |
| Treatment | |
| Eye-sparing surgery without adjuvant therapy | 59 (54.1) |
| Eye-sparing surgery with radiotherapy | 25 (22.9) |
| Eye-sparing surgery with chemoradiation | 9 (8.3) |
| Exenteration with chemoradiation | 10 (9.2) |
| Exenteration with radiotherapy | 3 (2.8) |
| Eye-sparing surgery, radiotherapy, and anti-PD1 | 1 (0.9) |
| Eye-sparing surgery, chemoradiation, and anti-PD1 | 2 (1.8) |
| FNA | |
| Yes | 30 (27.5) |
| No | 79 (72.5) |
| FNA result, No./total No. (%) | |
| Positive | 11/30 (37) |
| Negative | 19/30 (63) |
| Perineural invasion | |
| Positive | 40 (36.7) |
| Negative | 69 (63.3) |
| Laterality | |
| Bilateral | 4 (3.7) |
| Left | 65 (59.6) |
| Right | 40 (36.7) |
| N category at presentation | |
| N0 | 105 (96.3) |
| N1 | 4 (3.7) |
| M category at presentation | |
| M0 | 108 (99.1) |
| M1 | 1 (0.9) |
Abbreviations: FNA, fine-needle aspiration; M, metastasis; N, lymph node; PD1, programmed cell death protein 1.